• Species Reactivity

  Human, Mouse

• Specificity

  Detects human and mouse BACE-1 in direct ELISAs and human BACE-1 in Western blots. In Western blots, no cross-reactivity with recombinant human (rh) BACE-2, recombinant mouse (rm) BACE-2, rhADAM8, rmADAM9, rmADAM10, rhADAM15, or rhTACE is observed.

• Source

  Monoclonal Mouse IgG1 Clone # 137612

• Immunogen

  Mouse myeloma cell line NS0-derived recombinant human BACE-1    
  Thr22-Tyr460    
  Accession # P56817

• Formulation

  Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.

• Label

  Alexa Fluor 750

Applications

• Recommended    
  Concentration

  Sample

• Intracellular Staining by Flow Cytometry

  0.25-1 µg/10    ⁶ cells

  Jurkat human acute T cell leukemia cell line fixed with paraformaldehyde and permeabilized with saponin

• 
  

Please Note: Optimal dilutions should be determined by each laboratory for each application.  are available in the Technical Information section on our website.

Preparation and Storage

• Shipping

  The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

• Stability & Storage

  Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Background: BACE-1

BACE-1 (beta‑site APP cleaving enzyme-1) is an aspartic protease and an integral membrane protein (1, 2). It is the major beta secretase, and together with the gamma  secretase, is responsible for generating the amyloid beta peptide (A beta ) from the amyloid precursor protein (APP) (3, 4). Because A beta is a major component of amyloid plaques, BACE-1 has been implicated in the onset and/or progression of Alzheimer's disease. High levels of BACE-1 activity are sufficient to elicit neurodegeneration and neurological decline in vivo, indicating that inhibiting BACE-1 may block not only A beta -dependent but also A beta -independent pathogenic mechanisms (5). In addition to APP, BACE-1 also cleaves APP-like proteins 1 and 2, the cell adhesion protein P-selectin glycoprotein ligand-1 and beta -galactoside alpha 2,6-sialyltransferase, implying that BACE-1 may have additional functions involving the ectodomain shedding of membrane proteins (6‑8).

• References:

1. Vassar, R. et al. (1999) Science 286:735.

2. Yan, R. et al. (1999) Nature 402:533.

3. Cai, H. et al. (2001) Nature Neurosci. 4:233.

4. Roberds, S.L. et al. (2001) Human Mol. Genet. 97:1317.

5. Rockenstein, E. et al. (2005) J. Biol. Chem. 280:32957.

6. Li, Q and T.C. Sudhof (2004) J. Biol. Chem. 279:10542.

7. Lichtenthaler, S.F. et al. (2003) J. Biol. Chem. 278:48713.

8. Kitazynem, S. et al. (2005) J. Biol. Chem. 280:8589.

• Long Name:

  beta-site Ayloid Precursor Protein Cleaving Enzyme 1

• Entrez Gene IDs:

  23621 (Human); 23821 (Mouse)

• Alternate Names:

  APP beta-secretase; ASP2; Aspartyl protease 2; BACE1; BACE-1; BACEAsp 2; beta-secretase 1 precursor variant 1; beta-secretase 1; beta-site amyloid beta A4 precursor protein-cleaving enzyme; Beta-site amyloid precursor protein cleaving enzyme 1; Beta-site APP cleaving enzyme 1; beta-site APP-cleaving enzyme 1; beta-site APP-cleaving enzyme; EC 3.4.23; EC 3.4.23.46; FLJ90568; HSPC104; KIAA1149; memapsin-2; Membrane-associated aspartic protease 2; transmembrane aspartic proteinase Asp2